论文部分内容阅读
为阐明发生急性呼吸道病毒感染(ARVI)前,淋巴细胞中酶的变化,作者首先研究了血中淋巴细胞氧化酶的活性,在ARVI个人与群体之间发病率的相互关系。在17个月中,每月对42～46名9～11岁健康小儿测定淋巴细胞琥珀酸脱氢酶(SDH)及α-磷酸甘油脱氢酶(α-GPDH)的活性。有关14岁以下小儿及乌斯诺娃市所有居民每月平均ARVI发病率资料,来自该市卫生保健机构。通过酶的检测后,作者认为,健康小儿淋巴细胞脱氢酶平均活性降低发生于冬季ARVI发病率增高之前。如果14岁以下小儿中ARVI发病率与淋巴细胞α-GPDH酶活性呈负相关,那么所有城市居民的发病率也与淋巴细胞一种脱氢酶的活
To elucidate the changes in enzymes in lymphocytes before and after acute respiratory viral infection (ARVI), the authors first studied the relationship between the activity of blood lymphocyte oxidase and the incidence of individuals and groups in ARVI. In 17 months, the activity of succinate dehydrogenase (SDH) and alpha-glycerophosphate dehydrogenase (alpha-GPDH) in lymphocytes from 42 to 46 healthy children aged 9 to 11 were measured monthly. The monthly average ARVI incidence data for all children under the age of 14 and all residents of the city of Usnochow came from the city’s health care facility. Through the enzyme test, the authors believe that the average activity of healthy children with lymphocyte dehydrogenase occurred in the incidence of ARVI increased in winter before. If the incidence of ARVI in children under 14 years of age is negatively correlated with the activity of α-GPDH in lymphocytes, the incidence of all urban dwellers is also correlated with the activity of a dehydrogenase of lymphocytes